Economic evaluation with clinical trials in neonatology

Dmitry Dukhovny, John A F Zupancic

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

With the current economic climate, the budget crisis within the health-care system, and the rapid development of health-care technologies in the field of neonatology, it is essential for decision makers at every level to understand how to interpret published economic evaluations to help guide both practice and budget decisions. The objective of this article is to provide a stepwise approach to interpreting economic evaluations conducted alongside randomized, controlled trials (RCTs). The emphasis in assessing the validity of such an analysis is to ensure that the authors are transparent in their approach with respect to factors such as the intervention and comparator, time horizon, study perspective, sources for costs and effects, appropriate combining of costs and effects into a single metric, and assessment of uncertainty and time preference.

Original languageEnglish (US)
JournalNeoReviews
Volume12
Issue number2
DOIs
StatePublished - Feb 2011
Externally publishedYes

Fingerprint

Neonatology
Budgets
Cost-Benefit Analysis
Clinical Trials
Costs and Cost Analysis
Biomedical Technology
Climate
Uncertainty
Randomized Controlled Trials
Economics
Delivery of Health Care

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Economic evaluation with clinical trials in neonatology. / Dukhovny, Dmitry; Zupancic, John A F.

In: NeoReviews, Vol. 12, No. 2, 02.2011.

Research output: Contribution to journalArticle

Dukhovny, Dmitry ; Zupancic, John A F. / Economic evaluation with clinical trials in neonatology. In: NeoReviews. 2011 ; Vol. 12, No. 2.
@article{91b458b9af094a9e8aab12857a6ed939,
title = "Economic evaluation with clinical trials in neonatology",
abstract = "With the current economic climate, the budget crisis within the health-care system, and the rapid development of health-care technologies in the field of neonatology, it is essential for decision makers at every level to understand how to interpret published economic evaluations to help guide both practice and budget decisions. The objective of this article is to provide a stepwise approach to interpreting economic evaluations conducted alongside randomized, controlled trials (RCTs). The emphasis in assessing the validity of such an analysis is to ensure that the authors are transparent in their approach with respect to factors such as the intervention and comparator, time horizon, study perspective, sources for costs and effects, appropriate combining of costs and effects into a single metric, and assessment of uncertainty and time preference.",
author = "Dmitry Dukhovny and Zupancic, {John A F}",
year = "2011",
month = "2",
doi = "10.1542/neo.12-2-e69",
language = "English (US)",
volume = "12",
journal = "NeoReviews",
issn = "1526-9906",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Economic evaluation with clinical trials in neonatology

AU - Dukhovny, Dmitry

AU - Zupancic, John A F

PY - 2011/2

Y1 - 2011/2

N2 - With the current economic climate, the budget crisis within the health-care system, and the rapid development of health-care technologies in the field of neonatology, it is essential for decision makers at every level to understand how to interpret published economic evaluations to help guide both practice and budget decisions. The objective of this article is to provide a stepwise approach to interpreting economic evaluations conducted alongside randomized, controlled trials (RCTs). The emphasis in assessing the validity of such an analysis is to ensure that the authors are transparent in their approach with respect to factors such as the intervention and comparator, time horizon, study perspective, sources for costs and effects, appropriate combining of costs and effects into a single metric, and assessment of uncertainty and time preference.

AB - With the current economic climate, the budget crisis within the health-care system, and the rapid development of health-care technologies in the field of neonatology, it is essential for decision makers at every level to understand how to interpret published economic evaluations to help guide both practice and budget decisions. The objective of this article is to provide a stepwise approach to interpreting economic evaluations conducted alongside randomized, controlled trials (RCTs). The emphasis in assessing the validity of such an analysis is to ensure that the authors are transparent in their approach with respect to factors such as the intervention and comparator, time horizon, study perspective, sources for costs and effects, appropriate combining of costs and effects into a single metric, and assessment of uncertainty and time preference.

UR - http://www.scopus.com/inward/record.url?scp=79959875761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959875761&partnerID=8YFLogxK

U2 - 10.1542/neo.12-2-e69

DO - 10.1542/neo.12-2-e69

M3 - Article

VL - 12

JO - NeoReviews

JF - NeoReviews

SN - 1526-9906

IS - 2

ER -